P1146 VIROLOGICAL RESPONSE AND TOLERANCE TO BOCEPREVIR OR TELAPREVIR PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN TRIPLE THERAPY IN HIV–HCV CO-INFECTED PATIENTS: REAL-LIFE FINDINGS FROM THE PAN STUDY

✍ Scribed by Baumgarten, A.; Holm, S.; Lutz, T.; Schranz, D.; Mauss, S.; Hillenbrand, H.; Moll, A.; Scholten, S.; Schmidt, W.; Goelz, J.; Hintsche, B.; Schleehauf, D.; Fenske, S.; Stephan, C.; Prziwara, D.; Koeppe, S.; Alshuth, U.; Jaeger, H.

• Book ID: 122252406
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 61 KB
• Volume: 60
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(14)61306-4